SecSonar.com

RenovoRx, Inc. (RNXT)

RenovoRx, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

RenovoRx, Inc. (RNXT) is a Biotechnology company based in US with a market capitalization of $35M. Free cash flow was negative at -$11M. This page tracks RNXT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 10 employees · IPO Aug 26, 2021

Valuation

Valuation & price

$0.82 · as of May 17, 2026 · -41.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

6.45

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.34$1.04$0.75Jul 25Dec 25Jul 26Jul 7, 25$1.32Jul 9, 25$1.32Jul 11, 25$1.29Jul 15, 25$1.32Jul 17, 25$1.30Jul 21, 25$1.29Jul 23, 25$1.27Jul 25, 25$1.27Jul 29, 25$1.22Jul 31, 25$1.24Aug 4, 25$1.21Aug 6, 25$1.20Aug 11, 25$1.12Aug 13, 25$1.22Aug 15, 25$0.96Aug 19, 25$0.92Aug 21, 25$0.89Aug 25, 25$0.90Aug 27, 25$0.92Aug 29, 25$0.96Sep 3, 25$1.25Sep 5, 25$1.24Sep 9, 25$1.16Sep 11, 25$1.24Sep 16, 25$1.26Sep 18, 25$1.26Sep 22, 25$1.30Sep 24, 25$1.20Sep 26, 25$1.18Sep 30, 25$1.27Oct 2, 25$1.27Oct 6, 25$1.34Oct 8, 25$1.21Oct 10, 25$1.11Oct 14, 25$1.09Oct 16, 25$1.17Oct 21, 25$1.19Oct 23, 25$1.15Oct 27, 25$1.15Oct 29, 25$1.05Oct 31, 25$1.11Nov 4, 25$1.02Nov 6, 25$0.97Nov 10, 25$1.00Nov 12, 25$1.00Nov 14, 25$0.75Nov 18, 25$0.78Nov 20, 25$0.78Nov 25, 25$0.87Nov 28, 25$0.92Dec 2, 25$0.85Dec 4, 25$0.95Dec 8, 25$0.94Dec 10, 25$0.98Dec 12, 25$0.96Dec 16, 25$0.84Dec 18, 25$0.90Dec 22, 25$0.90Dec 24, 25$0.90Dec 29, 25$0.81Jan 2, 26$0.84Jan 6, 26$1.02Jan 8, 26$1.15Jan 12, 26$1.05Jan 14, 26$1.06Jan 16, 26$1.02Jan 21, 26$1.00Jan 23, 26$1.00Jan 27, 26$0.90Jan 29, 26$0.96Feb 2, 26$1.02Feb 4, 26$0.96Feb 9, 26$0.96Feb 11, 26$0.97Feb 13, 26$0.93Feb 18, 26$1.00Feb 20, 26$0.91Feb 24, 26$0.90Feb 26, 26$0.86Mar 2, 26$0.88Mar 4, 26$0.85Mar 6, 26$0.79Mar 10, 26$0.82Mar 12, 26$0.81Mar 17, 26$0.97Mar 19, 26$1.01Mar 23, 26$1.11Mar 25, 26$1.10Mar 27, 26$1.13Mar 31, 26$1.01Apr 2, 26$0.98Apr 7, 26$0.90Apr 9, 26$0.98Apr 13, 26$1.02Apr 15, 26$1.02Apr 17, 26$1.00Apr 22, 26$0.95Apr 24, 26$0.86Apr 28, 26$0.84Apr 30, 26$0.85May 4, 26$0.89May 6, 26$0.89May 8, 26$0.86May 12, 26$0.87May 14, 26$0.85May 18, 26$0.78May 20, 26$0.81May 22, 26$0.88May 28, 26$0.99Jun 1, 26$0.92Jun 3, 26$0.91Jun 5, 26$0.87Jun 9, 26$0.86Jun 11, 26$0.86Jun 15, 26$0.89Jun 17, 26$0.89Jun 22, 26$0.91Jun 24, 26$0.95Jun 26, 26$0.94Jul 2, 26$0.92
$0.7352-week range$1.40
Loading valuation history…

Fundamentals

Key fundamentals

$35M

Market cap

—

Revenue growth (YoY)

70.9%

Gross margin

-$11M

Free cash flow (USD)

-$6.9M

Net debt

Net cash position

49.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$43.0KFY 2025$1.1M
$0$1.1M

Free cash flow by year

2019 → 2025

FY 2019$-3.4MFY 2020$-3.5MFY 2021$-5.9MFY 2022$-8.8MFY 2023$-10.3MFY 2024$-9.1MFY 2025$-11.0M
-$3.4M-$11M

Gross margin by year

2024 → 2025

FY 2024100.0%FY 202570.9%
100.0%70.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.08)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDelisting NoticeJul 2, 2026Filing
  • 8-K eventEquity Incentive Plan AmendedJun 30, 2026Filing
  • Insider buyInsider Buy $20KVOLL MARK · Chief Financial Officer · $19.7KMay 21, 2026Filing
  • Annual report10-K FiledMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • FinancingSecurities RegistrationApr 16, 2026Filing

Questions

Frequently asked questions

What is RenovoRx, Inc.'s market cap?

RenovoRx, Inc. (RNXT) has a market capitalization of $35M.

What is RNXT's P/E ratio?

A meaningful P/E ratio is not available for RNXT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RNXT's price-to-book (P/B) ratio?

RNXT trades at 6.45 times book value per share.

When did RenovoRx, Inc. last report earnings?

RNXT last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying RNXT stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at RenovoRx, Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

SABS

SAB Biotherapeutics, Inc.

$34.6M

ALGS

Aligos Therapeutics, Inc.

$35.5M

INMB

INmune Bio, Inc.

$36.3M

ATHE

Alterity Therapeutics Limited

$36.5M

BTAI

BioXcel Therapeutics, Inc.

$37.1M

VERU

Veru Inc.

$37.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.